
Bolixtat 40mg Tablet
Marketer
Albia Biocare
Salt Composition
Febuxostat (40mg)
Overview Bolixtat 40mg Tablet
Gout, characterized by excessive uric acid crystallizing in joints, causing inflammation and pain, is effectively managed and prevented with the 40mg Bolixtat tablet. This medication lowers uric acid levels, and can be administered with or without food. Continuous use, as prescribed, is crucial; cessation may exacerbate symptoms due to renewed crystal formation. Dietary adjustments (e.g., limiting alcohol and red meat) and increased hydration are beneficial. Potential side effects include liver enzyme abnormalities, nausea, arthralgia, and skin rashes. Initial treatment might trigger a temporary flare-up of gout symptoms (intense joint pain, heat, and redness); however, discontinuing the medication is not recommended. Your physician may prescribe analgesics or other medications to alleviate these initial reactions. Report any signs of liver dysfunction, such as persistent nausea, darkened urine, or jaundice, immediately. Prior to commencing Bolixtat, inform your doctor of any existing cardiac issues, stroke history, thyroid disorders, or hepatic/renal impairment. Avoid use during pregnancy or breastfeeding; consult your physician for guidance. Regular blood tests monitor liver function during treatment.
Primary Ingredients of Bolixtat 40mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Bolixtat 40mg Tablet
Managing Gout
Major Benefits of Bolixtat 40mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 40mg Bolixtat tablet whole; do not damage it by chewing, crushing, or breaking. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Bolixtat 40mg Tablet:
- Nausea
- Skin rash
- Abnormal liver function
- Joint pain
- Rash
How to use Bolixtat 40mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Bolixtat 40mg Tablet can be administered with or without food; however, consistent timing is recommended.
How Bolixtat 40mg Tablet works:
Gout is triggered by elevated uric acid levels in the blood. Bolixtat 40mg tablets, a xanthine oxidase inhibitor, effectively lower these levels.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Bolixtat 40mg tablets. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Use of Bolixtat 40mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Bolixtat 40mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Bolixtat 40mg Tablet, which can induce dizziness, drowsiness, blurred vision, and paresthesia. These side effects could compromise safe driving.
KidneyCAUTION
Patients with severe kidney impairment should use Bolixtat 40mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised, as data on Bolixtat 40mg tablet use in such cases is limited.
LiverCAUTION
Patients with severe hepatic impairment should use Bolixtat 40mg tablets cautiously. Dosage modification may be necessary. Physician consultation is recommended. Data on Bolixtat 40mg tablet use in such patients is limited.
What if you forget to take Bolixtat 40mg Tablet :
Should you forget a Bolixtat 40mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bolixtat 40mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazole-based compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
